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I. INTRODUCTION 
Over the past twenty years, many veterinarians have faced the 
challenge of surgical ligation or partial attenuation of portasystemic 
venous shunts in dogs and cats. These congenital or acquired anomalous 
venous pathways allow nutrient and waste-laden blood returning from the 
small bowel, colon, spleen, and pancreas to bypass the liver and enter 
directly into the systemic venous circulation. Without portal venous 
blood, the liver is unable to perform the necessary metabolic and 
detoxifying functions that are essential to support life. The long term 
physiologic ramifications for the animal are staggering. Without some 
form of intervention, the prognosis for survival is at best guarded. 
Treatment of portasystemic shunt cases by medical therapy alone has been 
of little value (15,47). Due to the fact that shunts are a structural 
problem, surgical intervention has become the accepted mode of therapy, 
by itself or in combination with medical management. The surgical 
success rate with these extremely complex cases has improved through the 
years to only an acceptable level. 
Potential life threatening complications associated with surgery 
arise from a number of areas. From anesthetic complications, such as 
intraoperative renal shutdown, to bleeding disorders secondary to liver 
dysfunction. The primary complication is portal hypertension secondary 
to actual attenuation or total ligation of the venous shunt. 
The procedure for surgical correction of a single extrahepatic shunt 
has been reviewed in the recent literature (8,11,12,15). Even though 
guidelines for safe attenuation exist, an occasional animal still 
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succumbs to unexplained postoperative portal hypertension. It is 
probable that other psychological changes accompanying rapid surgical 
attenuation or ligation may play as much of a role in the development of 
postoperative shock, as does portal hypertension. It is for these 
animals that a method of controlled closure of a venous structure would 
be most advantageous. 
The portal vein of the dog and cat may be completely obstructed if 
the procedure is performed slowly over several weeks time (11). It 
seems reasonable to assume that complete obstruction of venous shunts 
could be accomplished without causing signs of portal hypertension if 
several weeks time were allowed for occlusion. Slow ligation would 
allow the liver parenchyma to adapt to the rerouted blood flow. It 
would also allow portal collateral circulation to accommodate any 
developing portal hypertension. 
Flexible carbon fiber has been used in human and veterinary medicine 
for the repair of damaged of severed ligaments and tendons (48). It 
demonstrates a high level of biocompatibility with tissues, as it induces 
the formation of mature collagenous fibrous tissue along its skeletal 
framework (21). Collagen deposition along the fibers has been reported 
to reach fifteen times the volume of the original carbon implant (21,25). 
Two criteria must be met for the collagen to form along the carbon fiber. 
l. The fibers must be implanted where a source of vascularized 
connective tissue and mesenchymal cells are readily available. 
2. The fibers must be implanted under a working load, i.e., tension 
(37). 
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It was my hypothesis that carbon fiber tow, when wrapped around a 
venous structure under tension, would produce a fibrous connective tissue 
reaction that would occlude the vessel in several weeks. Intralumenal 
portal pressures would provide constant static tension on the encircling 
carbons strands by forcing the vein wall out to meet the implant. This 
slow strangulation would allow the hepatic vasculature and the portal 
system to adapt to the steadily increasing portal pressure and avoid 
death due to acute portal hypertension. 
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II. LITERATURE REVIEW 
A. Evolution of Carbon as a Biomaterial 
The element carbon is unique in chemistry because of the vast number 
of compounds it forms. It serves as the basic building block in an 
estimated 1 million organic compounds, which are found widely distributed 
in nature. In the solid form, it is found in large amounts as coal and in 
smaller amounts as graphite, the pure crystalline form. It also 
surrounds us in the atmosphere as gaseous carbon dioxide. All plant and 
animal life is composed of complex organic compounds containing carbon 
in combination with hydrogen, nitrogen, oxygen, and other elements. 
The biocompatibility of elemental carbon has been recognized for 
centuries. Primitive societies used burnt bamboo splinters to perform 
tatooing as part of their cultural heritage (7). 
During the first half of the 20th century carbon was primarily used 
in industry. One of its main uses was for the formation of carbon black 
used in car tire production. During the second world war, advances in 
biomaterials research began to accelerate. Due to the need for refractory 
materials in the nuclear energy and aerospace fields new physical carbon 
forms were developed. These new, almost pure forms of carbon exhibited 
very low chemical reactivity (7). In 1967, a National Aeronautics Space 
Administration project was responsible for the recognition of carbon as a 
bio-compatible substance which was suitable for surgical implantation 
(7). 
Two forms of carbon were initially investigated in the medical 
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field, vitreous or glassy carbon, and high purity carbon yarn or 
filaments (7). Vitreous carbon has been used for the development of 
structural prostheses and tissue-to-prosthesis interfaces. Our only 
interest in this form is that its chemical composition is the same as 
that of carbon fiber. Vitreous carbon has been found to be extremely 
inert when implanted into human and canine tissues (7,43). The purity 
and consequently the chemical inertness and strength of all carbons 
considered for implantation is a function of the pyrolysis temperature in 
the final processing step. The higher the temperature, the purer the end 
products of heat decomposition (7). Early in the investigation of these 
two forms of carbon, wide variations in the purity of the final product 
existed between manufacturers (7). Processing has now been standardized, 
resulting in implantable products that are nearly 100% pure (41). 
1. Carbon f:l.ber 
Carbon fibers are available in multifilament, twist free bundles 
called "tows" (Fig. 1). Each individual filament is from 6-10 um in 
diameter (Fig. 1). Multiple longitudinal grooves run the length of each 
filament (Fig. 1). Tows are commercially available containing 1,000 
(lK) to 10,000 (10 K), filaments (Fig. 1) with the 10,000 filament tow 
being most widely utilized in clinical applications (3,4,17,23,27,34,51, 
52,54). 
Commercially available carbon fiber tow is subjected to a process 
called sizing, in which an epoxy resin is applied to the outer layer of 
the filaments. This allows the tows to be handled without fraying or 
falling apart when they are woven into fabrics by textile machinery 
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(3,23,51). These sizing resins are highly toxic to tissues (11,23,51). 
Tows to be implanted must either be purchased unsized, (3,17) or the 
epoxy resin must be completely removed by rinsing with chemical 
solvents (4,23,26,27,34,51,54). Methyl-ethyl-ketone (3,4,27,48,54) and 
acetone (3,26) have been used for this purpose. With the sizing removed, 
handling of the filaments becomes difficult. Medical grade carbon fiber 
tow is produced without epoxy sizing, but traces of silicone oil 
lubricant applied during manufacturing may contaminate the surface (3). 
Rinsing with cold petroleum ether will remove this residue (3). 
2. Polylactic acid and poly(t-caprolactone) 
Polylactic acid coated carbon fibers have been examined by several 
investigators (2,36). Polylactic acid coating of the carbon tows allows 
for easier handling, much like the epoxy resins. Polylactic acid 
undergoes gradual hydrolysis to lactic acid, and is then metabolized to 
carbon dioxide and water (2,36). Degradation may take several weeks to 
occur, but it is felt that the polylactic acid does not interfere with 
tissue response to the carbon (2,16,36). 
Poly(E-caprolactone) is a hydrolyzable polymer that has also been 
used as a sizing agent for carbon fiber (41). It is compatible with 
tissues, and degradation rate is directly related to the thickness of the 
coating layer. Random hydrolysis of ester linkages results in breakdown 
products of f-caprolactone and E-hydroxycaproic acid, which are water 
soluble and excreted in urine, feces, and expired water (37). 
Figure 1. Carbon fiber 
A. 3K, Carbon fiber tow, 4.0x 
B. 3K, Carbon fiber tow, (frayed) 8.0x 
c. Individual carbon filaments, 1300x 
D. Individual carbon filaments, 5800x 
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3. Tissue response 
The primary use of carbon fiber in human and veterinary surgery has 
been in the area of tendon and ligament repair (4,17,19,23,26,28,31,32, 
33,48,51,53,54). Its use has also been applied to the repair of abdominal 
incisional hernias in sheep, (30) and in correction of deviation of the 
bovine penis (34). Human and animal tissues react to the carbon scaffold 
in a unique manner. Abundant fibrous connective tissue and eventually 
mature collagen forms along the template of carbon fiber tow. Fibrous 
tissue may gradually increase until six to fifteen times the volume of 
the original implant is reached (21,25). This process has been called 
neotendon formation (18). 
Two important criteria must be met for this reaction to occur. 
First, the carbon must be implanted under a working load (21,38). When 
carbon fiber tow was chopped and inserted into muscle, intermuscular 
compartments, subcutaneously, around the calcaneal tendon, and into 
cortical bone in rats, rabbits and sheep, there was little or variable 
amounts of fibrous connective tissue formed (38). When carbon fiber was 
implanted both freely coiled and under a working load, it was found that 
only the fibers held under tension produced acceptable amounts of 
fibrous connective tissue (21,38). 
Secondly0 the carbon fibers must be implanted near a pool of 
vascularized connective tissue where mesenchymal cells or more 
specifically fibroblasts, are readily available (21,38). In New Zealand 
white rabbits that had carbon fiber achilles tendon replacement, removal 
of the posterior tibial nerve from the neuromuscular bundle resulted in 
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greatly diminished fibrous connective tissue production (21). In 
intact rabbits, carbon induced '"Neotendon'".rapidly developed from young 
fibroblastic tissue outgrowths of the loose mesenchymal tissue of the 
perineurium and adventitia of the blood vessels in the adjacent 
neurovascular bundle (21). 
At the cellular level, the reaction to carbon was described by 
Forster et al. as inert foreign body fibrosis (21). Inert foreign body 
fibrosis is a diffuse spread of fibrous tissue between or around the 
inert implant or foreign body, coupled with an absence of tissue 
necrosis and the presence of simple macrophage or foreign body giant cell 
reaction (21). It was concluded by Forster et al. that, '"The long term 
presence of single multinucleated cells coating the carbon filaments 
widely separated by masses of quiet fibrous tissue,'" was a ''clinically 
acceptable situation'" (21). Several investigators, concluded that 
implanted carbon fibers were well-tolerated and produced little evidence 
of causing an adverse inflammatory reaction (25,27). A slight 
eosinophilic response, noted by Mobini et al., was attributed to 
incomplete removal of polymer sizing from the carbon fibers (34). 
Goodship et al. examined filamentous carbon in fibroblast cell cultures 
and in vivo and determined that fibroblasts align themselves and grow 
along the grooves on the individual carbon filaments (23) (Fig. l). 
This physical scaffold encourages fibrous connective tissue to grow in 
an organized fashion similar to that of a natural tendon, unlike 
randomly formed scar tissue (23,34). As the neotendon develops, the 
carbon filaments undergo gradual mechanical failure. This structural 
11 
breakdown allows an increasing load to be placed on the neotendon and 
stimulates the newly formed fibrous tissue.to become oriented in the 
direction of the stress (21,23,27). Individual fragments of carbon may 
be engulfed by macrophages and removed to regional lymph nodes (25,27). 
Clinically, this does not present any problems (25,27). Tayton et al. 
investigated the carcinogenic potential of implanted carbon in Wistar 
rats and concluded that it was safe to use as an implantable biomaterial 
(49). 
4. Summary 
With proper preparation carbon fiber tow is an acceptable substance 
for surgical implantation. When implanted under tension, close to a 
source of vascularized mesenchymal cells, it produces abundant fibrous 
connective tissue on its skeletal framework. This connective tissue 
response may reach as much as 15 times the volume of the original 
implant. 
B. Anomalous Venous Systems in Small Animals 
1. Pathophysiology and clinicopathology 
The majority of animals presented with portacaval vascular anomalies 
exhibit some form of hepatoencephalopathy (93%), gastrointestinal 
disturbance (75%), or other clinical sign related to liver insufficiency 
(80%) (12). 
The exact mechanism of neurologic irritation is not known, but it 
is felt by most authors that ammonia plays a primary role (12). Plasma 
amino acid ratios, short chain fatty acids, and mercaptans may play an 
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important role (46). Byproducts of protein metabolism, amino acids and 
urea, are processed in the colon. Urease producing bacteria hydrolyze 
intestinal urea, and other bacteria deaminate amino acids to form 
ammonia. In the normal dog, ammonia is absorbed from the colon and is 
delivered to the liver by the portal venous system. In the liver, it is 
converted through the Krebs cycle into blood urea which is excreted by 
the kidneys. Dogs with diminished portal blood supply to the liver 
usually show increased concentrations of resting blood ammonia, and 
decreased concentrations of blood urea nitrogen (46,50). The degree of 
hyperammonemia does not always correlate with the severity of the 
clinical signs (12,46). 
Ammonia tolerance tests have been used as the primary biochemical 
diagnostic aid for the diagnosis of portasystemic shunts (46). A 
resting blood ammonia level is established, then 100 mg/kg ammonium 
chloride is administered orally. Thirty minutes post administration a 
second ammonia sample is obtained (5). A threefold increase indicates 
an inability of the liver to process the ammonia, and primary liver 
disease or portasystemic shunting is suspected. 
The gastrointestinal disturbances seen are primarily attributed to 
the nausea and bowel hypermotility that accompany high levels of toxic 
substances circulating in the blood stream. Overgrowth of intestinal 
anaerobes may also contribute to bowel abnormalities (46,50). 
Approximately one third of the animals presented with portasystemic 
shunts have a leukocytosis (12). This elevated white blood cell count 
is probably due to intestinal bacteria circulating in the blood stream 
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that normally should should have been filtered by the liver (12). 
The clinical signs related to liver insufficiency are usually subtle 
when compared with the neurologic or gastrointestinal abnormalities. 
Weight loss may be noted over a period of time with most animals. 
Decreased liver metabolism of proteins results in an ongoing state of 
catabolism (46,50). Hypoproteinemia is common in animals with liver 
insufficiency due to decreased hepatic production of albumin. Protein 
may also be lost in ascitic fluid if portal hypertension exists. 
Bleeding disorders may be seen due to decreased production of 
necessary clotting factors in the liver. Anemia may result secondary to 
blood loss, destruction of red cells, or decreased production (12). Red 
cells may also appear microcytic due to the toxic effects of ammonia in 
the alteration of heme synthesis (12). 
Polydipsia and polyuria when seen, result from primary hepato-
cellular dysfunction. Serum glutamic pyruvic transaminase, (SGPT), may 
increase to two times normal (12,46). This reflects hepatocyte 
degeneration secondary to nutritional derangements or endotoxemia (46). 
Serum alkaline phosphatase, (SAP), is variably elevated, and may rise 
secondary to gastrointestinal disturbances (46,50). 
2. Anatomy and surg:l.cal considerations 
In normal animals, the liver receives twenty to twenty-five per cent 
of its blood flow from the hepatic artery, and the portal vein provides 
the remaining seventy-five to eighty per cent (12). The venous and 
arterial blood mixes in the sinusoids for hepatocellular processing. 
With anomalous venous systems, blood from the small bowel, colon, spleen, 
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and pancreas follows the path of least resistance into the inferior vena 
cava and the systemic circulation (12). 
Five major types of macrovascular, anomalous venous systems have 
been recognized in the dog and cat (18,46). Macrovascular patterns 
account for ninety-eight per cent of all clinical cases seen. They are 
1. persistent ductus venosus, (left or right), 2. portacaval shunt, 3. 
portal azygos shunt, 4. mesenteric or splenorenal collaterals, and 5. 
portal azygos shunt with discontinuation of the prerenal postcava 
(18,46). Structural variations may occur within each of these groups 
(12). Approximately twenty-eight per cent of all clinical cases present 
with intrahepatic patent ductus venosus (12). Demanding surgical 
techniques to repair intrahepatic shunts have been developed (12,13). 
The remaining seventy per cent are single (50%), or multiple (20%), 
extrahepatic shunts (12). Multiple extrahepatic shunts are usually 
formed secondary to primary liver disease, and are not good candidates 
for surgical repair (12). Single extrahepatic shunts are by far the 
most amenable to surgical repair. Several authors have reviewed the 
surgical techniques (8,10,11,47). 
Attenuation or ligation of a shunt is performed only when portal 
pressures are measured by a water manometer or strain gauge transducer 
(11). Communication between the measuring device and the portal system 
is accomplished via an eighteen or twenty gauge catheter inserted into a 
sacrificable branch of a jejunal vein. The base of the manometer should 
be centered at the level of the right atrium (8,11,12). The level of 
the right atrium may be found by measuring one half the distance from 
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the sternum to the dorsal spinous process at the third intercostal space 
(28). It may be approximated by resting the base of the manometer in 
the inguinal canal of an animal in dorsal recumbancy (11). After a 
midline celiotomy, and experienced surgeon can often identify the shunt 
where it enters the inferior vena cava, cranial to the renal veins (12). 
If the shunt can not be identified grossly, positive contrast portal 
venography should be performed. Once the shunt has been located, it 
should be dissected from the surrounding mesentery. Suture material is 
placed around the shunt and is slowly tightened until a portal pressure 
of twenty to twenty-three centimeters of water, or sixteen to eighteen 
millimeters of mercury is attained (12). If the pressure does not rise 
above twenty-three centimeters of water with the anomalous vessel 
completely occluded the vessel is permanently ligated (11,12). Sudden 
elevation of portal venous pressure above twenty-five centimeters of 
water may result in compromised splanchnic perfusion, severe portal 
hypertension, ascites and death (12). Some dogs cannot survive even acute, 
moderate portal hypertension (12). Following attenuation or ligation of 
anomalous vessels, several patients have died even though the measured 
portal pressure did not exceed accepted limits (11). 
Conversely, E.M. Breznock has stated, "The portal vein of the dog 
and cat may be completely obstructed if the procedure is performed slowly 
over several weeks time before complete obstruction is realized" (12). 
3. Summary 
Animals with anomalous venous systems, (portasystemic shunts), are 
unusually presented with clinical of neurologic dysfunction, gastro-
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intestinal disturbance, or other signs of hepatic insufficiency. 
The ammonia tolerance test serves as a useful diagnostic aid. Total 
proteins, albumin, blood urea nitrogen (BUN), serum glutamic pyruvic 
transaminase (SGPT), and serum alkaline phosphatase (SAP), and complete 
blood counts serve as useful clinicopathologic tools in monitoring portal 
blood supply to the liver. 
One half of all the cases, (single extrahepatic shunts), lend 
themselves to reasonable surgical repair. Unexplained, sudden death 
still occurs with partial attenuation or complete ligation of some 
shunts, even when guidelines for safety are followed. 
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III. MATERIALS AND METHODS 
A. Animals 
Fifteen preconditioned young adult dogs (estimated to be 
approximately 1-5 years old) were obtained from the Laboratory Animal 
Resources department of the College of Veterinary Medicine, Iowa State 
University. All dogs had been vaccinated with Norden laboratory's 
Vanguard DA2PL and Fromme laboratory's Rabvac. All dogs were wormed with 
Strongid T and were confined at the Laboratory Animal Resources farm for 
three weeks prior to the initiation of the project. There were 9 
females and 6 males all weighing between 10 and 20 kilograms. They were 
maintained on pelleted dry food containing 24.5% protein, and 6.2% fat 
throughout the study. Each animal was evaluated by physical 
examination, complete blood count, heartworm test, and serum chemistries 
including glucose, urea nitrogen, alkaline phosphatase, pyruvic glutami.c 
transaminase, and ammonia tolerance tests. If the dogs were found to be 
normal by all parameters measured, they were entered in the study. 
B. Experimental Design 
Each animal was randomly assigned to one of three groups. The first 
group of six dogs received 3K, polycaprolactone coated, double wrapped 
carbon sutures around their portal veins. Double wrapped 2-0 chromic 
catgut was substituted in place of carbon in the second group of six 
dogs. The third group of three dogs served as control animals. The 
surgical dissection around the portal vein was performed, the sutures 
were placed and then removed prior to closure of the abdomen. 
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All animals were induced with thiopental and maintained on halothane 
gas anesthetic. Lactated ringers was administered through a cephalic 
catheter at the rate of lOml/kg for the first hour and 5 ml/kg for the 
second hour. A ventral midline incision was made from the xiphoid 
cartilage to a point 4 cm caudal to the umbilicus. Saline moistened lap 
sponges and a balfour retractor were placed to aid in visualization. A 
segment of the jejunum was isolated and an 18 gauge intravenous catheter 
was inserted into the jejunal vein. It was fixed firmly in place with 
4-0 nylon sutures around the shaft and the hub of the catheter. The 
catheter was then attached to a 36 inch, heparanized saline charged 
extension set and water manometer fitted with a three way stopcock at 
the base. A baseline portal pressure was measured and recorded with the 
base of the manometer leveled at the height of the right atrium. The 
level of the right atrium was determined by measuring one half the 
distance from the sternum to the dorsal spinous process at the 3rd 
intercostal space (28). Careful measurements of the table, dog, and 
manometer base height were recorded to insure that identical 
measurements could be repeated -at a later date with each animal. The 
portal vein was isolated by gentle retraction of the duodenum to the 
left side of the abdomen. All implants were placed around the portal 
vein approximately one inch cranial to the point of entry of the last 
identifiable jejunal vein. Using a Halstead hemostat, the mesentery was 
gently separated away from the portal vein to allow implant passage. 
The catgut or carbon strands were then double wrapped around the vein 
and gently tightened until a 1 to 4 cm of water increase was attained on 
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the water manometer. Four throw knots were used consistently with both 
carbon and catgut. After knotting, the portal pressure was again 
checked and recorded. At this point, the carbon sutures were cut free 
from the control dogs and the portal pressure was again measured. The 
tip of the left lateral liver lobe was removed by the guillotine 
technique using 2--0 chromic catgut. 
The abdomen was then temporarily closed with the jejunal catheter in 
place and the extension set protruding through the incision and the 
animal was transported to radiology. Two view portal venography was 
then performed under stringent conditions to insure reproducibility at a 
later date. A Harvard infusion pump was used to deliver 50% Hypaque at 
a rate of 12 cc's in 18 seconds. Using a rapid film changer, exposures 
were taken at 12, 14, 16, and 18 seconds in both lateral and ventral-
dorsal recumbancy. 
The dog was returned to surgery where the jejunal catheter was 
removed and the jejunal vein ligated. The abdominal incision was closed 
with simple interrupted 0 prolene sutures in the abdominal wall, and 
simple interrupted 2-0 catgut subcutaneous and subcuticular sutures. A 
continuous Ford interlocking of 4-0 nylon was used for skin closure. The 
surgical procedures performed were carefully monitored to insure 
consistency in all details. 
Rectal temperature, appetite, attitude, and stool consistency were 
monitored for the first week post implantation. Appetite, attitude, 
stool consistency, and weekly body weights were monitored thereafter. 
At the eight week point, all animals were returned to surgery. 
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Jejunal catheters were placed as previously described and portal 
pressures measured. Portal venography was.repeated using the same 
criteria as before. The dogs were euthanatized and photographs of the 
implant site were taken. The implant site, liver, kidney, small bowel, 
pancreas, and regional lymph nodes were saved for histopathology. 
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IV. RESULTS AND DISCUSSION 
A. Portal Venography 
The attempt to document lumen closure by the use of portal 
venography proved to be a highly inaccurate technique. Even though every 
attempt was made to standardize the procedure, results were erratic 
suggesting the introduction of numerous variables. Fifteen of the 30 
radiographic views taken showed sizeable increases in lumen diameter at 
the implant site. However, findings on post mortem exam and from the 
histologic reactions seen, it is highly unlikely that lumen enlargement 
actually occurred. 
Two radiologists independently measured dye columns at the level of the 
implant sites. Four exposures (12,14,16, and 18 seconds) were taken of 
each view, (lateral and ventral-dorsal) immediately post implantation and 
at the 8 week sacrifice. The mean of the four post implant measurements 
was compared with the mean of the four measurements for that respective 
view at the 8 week sacrifice. Both radiologist's results were kept 
separate and the two sets of data were compared. 
To discuss the actual results of the measurements would be futile. 
Enough variability existed between the individual radiologists 
measurements that a discussion of the reasons for error would be more 
appropriate. 
The first area identified as a problem was the radiographic 
phenomena of contrast streaming. As Hypaque dye mixes with the portal 
blood, the dilutional effect in addition to the movement of the blood and 
dye past the implant site may cause a lack of positive contrast that is 
22 
very unpredictable. Turbulence created by the decreased lumen diameter 
at the implant site may also cause distortion of the contrast column. 
Without the ability to clearly delineate the vein wall accurate 
measurements are impossible. I had attempted to circumvent this problem 
by using large amounts of contrast agent (12cc) administered over a 
sustained length of time (18 seconds). A Harvard infusion pump was used 
for this purpose and also to maintain a constant pressure on injection. 
The second problem encountered as a variable between the two 
radiologists was the identification of the exact implant location. With 
several animals the implant site was narrowed for a variable distance. 
Each radiologist had to choose the spot that they felt was the narrowest 
portion of the lumen, and in some cases this varied. 
Several other problem areas beyond the control o~ the radiologists 
were identified. The positioning of the portal vein within the animal 
was altered at the time of surgical implantation of the catgut or carbon. 
The viscera was shifted to the left side of the abdominal cavity by 
retraction of the descending duodenum. Physical dissection was performed 
around the portal vein with a Halstead hemostat and implants were placed 
and positioned. The viscera was replaced, the abdomen closed, and the 
first set of portal venograms was performed. Upon recovery, the abdominal 
viscera certainly returned to a more natural position moving with it the 
portal vein. This movement, although slight could make major differences 
when results are measured in fractions of millimeters. 
At the time of implantation, it was noticed that the portal veins 
remained indented on all three of the control dogs after the implants 
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had been removed. This constricted area was visible on portal venography 
immediately following the surgery in two of the three dogs. I attribute 
this sustained artifact to contraction of the small amount of smooth 
muscle found within the portal vein wall. Portal vein diameters 
increased in all three of the control dogs over the course of the study. 
I suspect that the smooth muscle under the carbon and catgut implants 
may also have responded in the same manner. With relaxation of the 
smooth muscle the vein wall would expand out to meet the resistance of 
the encircling implant. 
Eleven of the 15 animals gained weight during the course of the 
study. This increase in abdominal fat could have altered radiographic 
measurements by changing the position of the portal vein or increasing 
the distance between the portal vein and the film cassette. A magnifying 
effect occurs as objects are moved away from the film and towards the 
beam. 
Other physiological factors that could cause variability in the size 
of the portal vein, are the phase of respiration at time of exposure, 
marked changes in systolic or central venous pressures, and the hydration 
state of the animal. 
It is my feeling that the number of variables, both human and 
physiological., are too numerous to overcome. As medicine has been 
described as an inexact science, so in this instance is radiology. 
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B. Clinical Pathology 
Clinical pathological monitoring was performed at three times during 
the study. Prior to implantation, at the midpoint, (4 weeks) and prior 
to sacrifice, (8 weeks) the following parameters were monitored. White 
blood cell counts, including PCV, Hb, total protein, and fibrinogen. 
Serum chemistries included glucose, albumin, urea nitrogen, (BUN) 
alkaline phosphatase, and glutamic pyruvic transaminase. Ammonia 
tolerance tests were also performed. 
All parameters measured over the eight weeks of the study were found 
to be normal, with only two exceptions. Two dogs (5334 Catgut and 5378 
Control) exhibited a moderate leukocytosis with a left shift at the 
midpoint of the study. They did not exhibit any clinical signs 
suggestive of the cause of the white cell response. Their appetites and 
attitudes remained normal, but both had a mild elevation of their rectal 
temperature, 103.0 and 102.8, respectively. The rectal temperatures 
returned to normal in 48 hours and the leukocytosis and left shift were 
gone when the final blood counts were run before sacrifice. No evidence 
of infection was found at post mortem exam. 
If reasonable occlusion of the portal vein would have been achieved, 
marked ch~nges in the blood picture would have been expected. 
Portal Pressures (Table 1) 
Resting portal pressures were measured prior to manipulation of the 
portal vein, after the implant was in place, and at the 8 week point 
prior to the second series of portal venograms. Table 1 is a summary of 
the recorded measurements. The "Difference" column on the far right side 
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Table 1. Summary of portal pressures in centimeters of water 
Dog It Implant Resting Post Implant 8 Wk Portal Diff. 
Type Portal Pressure Portal Pressure Pressure 
5214 Carbon 7.6 9.4 10.0 +o.6 
5309 Carbon 10.6 14.0 11.0 -3.0 
5337 Carbon 10.6 9.6 9.6 o.o 
5412 Carbon 10.0 10.8 11.0 +o.2 
5465 Carbon 7.8 8.2 8.0 -0.2 
5634 Carbon 7.0 8.2 8.2 o.o 
5235 Catgut 8.0 10.2 19.0 +8.8 
5333 Catgut 8.0 10.6 10.0 -0.4 
5334 Catgut 10.6 12.2 9.6 -2.6 
5409 Catgut 10.4 10.6 9.4 -1.2 
5417 Catgut 9.0 10.6 12.0 +1.4 
5466 Catgut 8.2 9.6 12.9 +3.3 
Post Implant 
Removal Pressure 
5171 Control 7.3 7.2 10.2 +3.0 
5378 Control 8.6 8.6 9.4 -0.8 
5411 Control 8.4 9.6 12.0 +2.4 
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of the table is the measured change in portal pressure from the time of 
implantation until sacrifice. 
A negative value in this column would indicate a decrease in the 
portal pressure between the time of implantation and sacrifice. This 
would be expected if little fibrous connective tissue was formed and the 
portal vein remained patent. The portal system has a remarkable ability 
to adapt to moderate increases in portal pressures. 
A positive value in this column indicates a rise in the portal 
pressure that we expected to see if the portal vein was slowly being 
occluded. Five of the twelve implant dogs exhibited a rise in pressure, 
but so did two of the three control dogs. This would suggest that other 
factors played an important role in determining the measured pressures. 
Since the same measurement techniques were used for all readings, the 
variability must lie within the dog's own physiologic processes. 
Variability in hydration state, systolic blood pressure, central 
venous pressure, and position of the abdominal viscera could all play a 
role in the measurement of portal pressures from one day to the next. 
The variability in the results of this study indicate that setting exact 
guidelines for maximum portal pressures may lead to error on the part of 
the surgeon. 
Dog 5337. serves as one example. Baseline portal pressures were 
measured and checked twice. A reading of 10.6 cm/water was obtained for 
the reading both times. After dissection around the portal vein and the 
placement of a double wrapped carbon ligature that indented the wall of 
the vein approximately 25%, the portal pressure was rechecked two times 
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and was. found to be 9.6 cm/water. The catheter was flushed and the 
manometer recharged to insure that no errors were made, and again the 
pressure was 9.6 cm/water. With the portal vein partially occluded by 
the ligature it is hard to understand how the post implant pressure could 
be lower. 
Dog 5235 also exhibited peculiar portal pressure responses when the 
double wrapped 2-0 chromic catgut suture was applied. The catgut was 
tightened around the vein until approximately 50% of the portal vein lumen 
was occluded. The manometric pressure elevated only by 2.2 cm/water to 
10.2 cm/water. The suture was loosened and the catheter and manometer 
were flushed to insure a patent system. Upon reapplication of the 
catgut, identical tension was required to reach a pressure of 10.2 
cm/water. 
These two dogs illustrate that portal system pressures do not always 
respond in a consistent manner to closure of the portal vein. 
D. Post Mortem Exam 
On post mortem exam, 13 of the 15 dogs showed a remarkable amount of 
external capsular fibrosis of the left lateral lobes of the liver. This 
is the area where the liver biopsy specimen was removed at the time of 
implant placement. The external capsule was traumatized as the assistant 
retracted the liver lobe caudal to the incision for ease of removal of 
the biopsy specimen. Histologic examination confirmed that no damage 
occurred below the level of the external capsule. 
The implant sites appeared very quiet, with no signs of inflammation 
or undesired fibrosis in the surrounding tissues. Only one catgut 
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implant dog had a small adhesion of the omentum to the implant site and 
also to the left lateral liver lobe where the tip had been removed. 
The catgut and carbon sutures were easily visualized. Little if any 
fibrous connective tissue formation could be seen. Each portal vein was 
opened through the implant site to check for signs of internal lumen 
narrowing. The indentations seen in the portal vein under each implant 
varied, depending on the amount of tension that had been applied to the 
carbon or catgut at the time of placement. Additional narrowing of the 
lumen due to fibrous connective tissue formation was not noted. The 
intimal surfaces were smooth and no signs of thrombus formation were 
seen. 
E. Histopathology 
Histopathologic examination was performed on sections of the 
implant sites, liver, duodenum, jejunum, regional lymph nodes, pancreas, 
and kidneys. All cellular or structural abnormalities were graded on a 
zero to four plus scale. A zero indicated a total lack of the cellular 
response or structural change being examined. A one plus rating 
indicated the presence of a cellular component in low numbers or a 
minimal amount of structural change. Two plus indicated a moderate 
number of the specific cellular components or a moderate amount of 
structural change. Three plus indicated a marked amount of a specific 
cellular components or a marked amount of structural change. The four 
plus rating indicated the maximum cellular or structural response seen in 
the specimens being evaluated. A mean grade was obtained for the 
cellular response or structural change for the dogs in each group (i.e., 
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carbon, catgut, and controls). 
1. Pancreas 
No significant lesions were seen in the pancreatic tissue. With 
its close proximity to the implant site on the portal vein, the quiescent 
appearance of this sensitive glandular structure suggested a lack of 
inflammation in the soft tissues adjacent to the carbon or catgut. 
2. Duodenum and jejunum 
No significant lesions were seen in the small bowel sections. If 
significant portal hypertension had occurred, we would have expected to 
find hemosiderin laden macrophages, and/or congestion in the lamina 
propria. 
3. Kidneys 
The kidneys were evaluated for the presence of peripelvic or 
interstitial lymphocytes and plasma cells, dilated glomerular 
capillaries, mineralized casts, prominence of the juxtaglomerular 
apparatus, and old dog inclusion bodies. Mineralized casts, considered 
to be normal background lesions, were seen in 13 of the 15 dogs. All 
other cellular or structural changes in the renal tissue were 
insignificant. 
4. Liver 
Hepatic tissue was evaluated for dilatation of the portal veins, 
centrilobular vacuolar degeneration, cholestasis, old dog inclusion 
bodies, portal vein polymorphonuclear lymphocytes, dilated lymphatics, 
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lipogranulomas, surface fibrosis and eosinophils, and hemosiderin 
deposits. Centrilobular, vacuolar hepatocellular degeneration of mild to 
moderate severity was noted in all animals, on both the pre-implant 
biopsy and the sections taken at sacrifice. Vacuolation within 
hepatocytes was diffuse throughout the cytoplasm suggesting intracellular 
accumulation of glycogen or water. The grading system indicated that as 
a group there was a decrease in centrilobular hepatocyte vacuolation over 
the eight weeks of the study. If impairment of blood flow through the 
portal vein had been achieved, we would not have expected to see an 
improvement in the histologic character of the liver parenchyma (18). 
No other significant changes were seen in the liver sections. 
5. Lymph nodes (Table~ 
Regional lymph nodes were evaluated for the presence of primary and 
secondary follicles, plasma cells, hemosiderin, eosinophils, sinus 
histiocytes, red blood cells in the sinuses, and erythrophagocytosis. 
Lymphatic tissue adjacent to both carbon and catgut showed a tendency 
towards the formation of secondary follicles (Fig. 2). Secondary 
follicles develop within the lymph node during periods of increased 
functional activity (24). 
Plasma cells were noted in higher numbers among the catgut implant 
group (x=2.17) when compared with the carbon (x=l.33) and control (x=l.O) 
groups. The increased presence of plasma cells is indicative of an 
increased ability to produce antibodies. This seems reasonable as the 
protein component of the catgut should be recognized by the body and 
defenses as a foreign antigen. Equally interesting is the apparent lack 
Figure 2. Histopathology 
A. Lymph no~e, secondary follicles, 75x 
B. Splendore-Hoeppli Phenomenon, 475x 
c. Fibroblast alignment along carbon filaments, 195x 
D. Fibroblast alignment a!ong carbon filaments, 485x 
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:Table 2. Summary of histologic responses in regional l}>mph nodes to 
carbon and catgut implants 
Dog II Implant Type Secondary Follicles Plasma Cells Eosa SHb 
5214 Carbon +++ + ++ + 
5309 Carbon ++ ++ + 0 
5337 Carbon +H+ + .+ ++ 
5412 Carbon +H+ ( + +++ + 
5465 Carbon +++ ++ + + 
5634 Carbon ++ + + + 
Total 18 8 9 6 
Mean 3.0 1.33 1.5 1.0 
5235 Catgut +++ +H+ + +++ 
5333 Catgut ++ ++ +H+ 0 
5334 Catgut + + +++ + 
5409 Catgut ++ ++ + 0 
5417 Catgut +H+ + + 0 
5466 Catgut +++ +++ +++ + 
Total 15 13 13 5 
Mean 2.5 2.17 2.11 .83 
5171 Control ++ ++ 0 0 
5378 Control ++ + 0 0 
5411 Control ++ 0 0 + 
Total 6 3 0 1 
Mean 2.0 1.0 0 .33 
aEosinophils. 
bsinus Histiocytes. 
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of increased plasma cell numbers in response to poly(E-caprolactone) 
coated carbon. It is probable that carbon.has less antigenic potential 
than chromic catgut. 
Eosinophil populations were elevated with both the carbon (x=l.5) 
and catgut (x=2.17) groups when compared with the control group (x=O). 
Eosinophil presence has been associated with a T-lymphocyte response, and 
an activation of cell mediated immunity within the lymph node (56). 
This reaction was most pronounced within the lymph nodes associated with 
the catgut group. 
Sinus histiocytes were noted to have increased minimally within the 
lymphoid tissue of the carbon (x=l.O) and catgut (x=.83) group when 
compared with the control group (x=.33). Recently, sinus histiocytes have 
been reclassified as a previously undescribed stage of B-lymphocytes 
(44). Most often B-lymphocytes play a primary role in the production of 
antibodies (35). No other significant changes were seen within the 
lymph nodes. 
The reader should be reminded that the grading system used, provided 
a subjective quantitation of the cellular components present. This 
grading system was only used to establish trends or tendencies, not to 
collect hard data for statistical analysis. It should also be noted that 
the mesenteric lymph nodes harvested may also receive lymphatic drainage 
from areas beyond the implant site. Local or generalized infections, 
parasitic infestations or generalized allergic reactions could influence 
the cellular changes within these lymph nodes. 
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6. Implant site (Table~ 
Sections of the implant site were prepared by cutting the tissue at 
right angles to the longitudinal axes of the implants. The amount of 
fibrosis associated with the catgut group (x=3.17) actually exceeded 
that of the carbon group (x=2.00). 
The cellular reaction to the carbon filaments was a granulomatous 
response. Granulomas are characterized by the infiltration, maturation 
and aggregation of young mononuclear phagocytes. The reaction to the 
carbon filaments is consistent with classification as a "low turnover" 
granuloma. Low turnover granulomas show little evidence of macrophage 
death, immigration, or mitosis (9,56). They are produced in response to 
poorly degradable chemically inactive, nontoxic substances (1). 
Almost all of the cellular activity seen in association with the carbon 
occurred within the implant itself (Fig. 3). Individual carbon 
filaments had been forced apart by the newly formed fibrous connective 
tissue, increasing the diameter of the fiber from within. Macrophages, 
multinucleated giant cells, endothelial cells in new capillaries, and 
fibroblasts were the predominant cell types seen interspersed between 
the separated carbon filaments (Fig. 3). It is thought that 
multinucleated giant cells are produced by the fusion of macrophages as 
a result of simultaneous attempts to ingest the same particle of foreign 
material (56). Blood-filled capillaries were noted with regular 
frequency in the new connective tissue between carbon filaments. 
' 
Fibroblasts were found in moderate numbers and did appear to align 
themselves along the individual carbon filaments as seen in longitudinal 
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Table 3. Summary of histologic responses for carbon and catgut 
implants 
Dog II Implant Type Fibrosis Macrophages Lyphocytes MNGCa PMNb 
5214 Carbon ++ + + ++ 0 
5309 Carbon +++ + 0 + 0 
5337 Carbon + + ++ + 0 
5412 Carbon +++ + 0 0 0 
5465 Carbon + + + + 0 
5634 Carbon ++ + 0 + 0 
Total 12 6 4 6 0 
Mean 2.00 1.00 .67 1 0 
5235 Catgut +++ +++ ++++ 0 + 
5333 Catgut +++ ++ + ++ + 
5334 Catgut +++ ++ + 0 + 
5409 Catgut ++++ ++ + 0 + 
5417 Catgut ++ ++ + 0 + 
5466 Catgut ++++ +++ 0 0 + 
Total 19 14 8 2 6 
Mean 3.17 2.33 1.33 .33 1 
aMulti Nucleated Giant Cells. 
bPolymorphonuclear Leucocytes. 
Figure 3. Carbon implant 
A. Carbon implant, dog 5465, 30x 
B. Carbon implant, dog 5465, 75x 
c. Carbon implant, dog 5465, 195x 
n. Carbon implant, dog 5465, 475x 
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section (Fig. 2). Total fibrous connective tissue formation within the 
carbon tow was estimated to produce only a.one fold increase in the 
diameter of the original implant. This amount of fibrous connective 
tissue was far less than had been reported in tendon repair research. 
No neutrophil or eosinophil response to the carbon was noted. Dense 
rings of an intensely eosinophilic substance were seen surrounding 
several carbon filaments cut in cross section (Fig. 2). This condition 
has been described as the Spendore-Hoeppli Phenomenon, named for the men 
who first described it (29). It is believed to be an in vivo antigen-
antibody percipitate, which has been seen in association with fungi, 
helminths, gram negative bacteria, and silk sutures (29). 
The cellular reaction to catgut occurred at the periphery of the 
fiber with no invasion into the suture material. The fibrous connective 
tissue formation, secondary to the degradation of chromic catgut was much 
more dramatic than we had expected. The production of mature fibrous 
connective tissue secondary to catgut implantation consistently exceeded 
that of the carbon group. 
The inflammatory reaction to catgut could also be described as 
a granulomatous response. Macrophages ~ould be seen attached to small 
portions of the peripheral catgut, and multinucleated giant cells were 
not prevalent. Polymorphonuclear leucocytes in small numbers were seen 
in association with the catgut sutures. 
Figure 4. Catgut implant 
A. Catgut implant, dog 5466, 30x 
B. Catgut implant, dog 5466, 75x 
c. Catgut implant, dog 5466, 195x 
D. Catgut implant, dog 5466, 475x 
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V. SUMMARY AND CONCLUSIONS 
The induction of fibrous connective tissue on or within the 
skeletal framework of carbon fiber tow occurred in insufficient 
quantities to achieve the goal of this study. Fibrous connective tissue 
produced at a rate of 8-15 times the implant, as has been reported, 
would have been adequate to a least partially occlude the portal vein. 
The studies performed by Ralis and Forster emphasized the need for a 
source of vascularized connective tissue and mesenchymal cells, and that 
a functional working load be placed on the carbon filaments. The 
cellular components were present on histopathology in both carbon and 
catgut groups, and appeared to be readily available. The question that 
we could not answer at the onset of study was if the lumenal pressures 
of the portal vein pushing outward on the encircling implant would 
provide a sufficient working load. The results are clear. The low 
pressures found within the portal system are insufficient to place a 
functional amount of tension on the carbon fiber. Without adequate 
tension, a minimal amount of fibrous connective tissue was formed. The 
response to the carbon by the body's cellular defense system was 
classified as a low turnover granuloma. This was considered to be a 
biocompatible situation as low turnover granulomas form in response to 
inert foreign material. 
Chromic catgut also produced an inflammatory granulomatous response 
forming more mature fibrous connective tissue than the carbon filaments. 
The volume formed was judged to be insufficient to adequately provide 
closure of a venous structure. Although the collagen formation was 
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minimal, catgut may serve as a useful adjunct to nonabsorbable suture 
materials such as silk or nylon when partial attenuation of a 
portasystemic shunt is attempted. Using the nonabsorbable suture 
material to partially attenuate the vessel and achieve acceptable 
pressures, a second ligature of chromic catgut could be applied directly 
over it. Any reduction in lumen size would be at best minimal, but 
helpful. Increasing the volume of.the catgut encircling the shunt may 
aid in forming more fibrous connective tissue. 
Poly(E-caprolactone) worked well as a sizing material. The carbon 
filaments were easy to handle and no evidence of adverse tissue 
reactions was obtained. 
The use of portal venography as an instrument to document lumen 
closure, proved to be a highly inaccurate technique. As discussed 
previously, a number of variables such as change in position of the 
portal vein, make accurate documentation of the lumen closure 
impossible. Contrast streaming occurred consistently making lumen 
diameter measurements vary greatly. The ability of the normal portal 
system to adapt to increased fluid volumes, such as rapidly injected 
Hypaque, made consistent distention of the portal vein difficult. It is 
my feeling that the use of portal venography should be used only as a 
diagnostic aid to locate anomalous venous structures and never as a 
measurement device. Much has been written about the use of portal 
pressures as a guideline for attenuation of portasystemic shunts. A 
maximum portal pressure of 23 centimeters of water is considered safe 
when attenuation or ligation of a shunt is attempted. I would caution 
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any surgeon performing this task to adhere loosely to these guidelines. 
With the variable pressure measurements I encountered in this study, it 
would seem easy to push too close to the high end of the guidelines, 
only to find that your measured pressure was inaccurate and actually 
higher than you thought. Upon recovery of the animal, portal 
hypertension might occur. In application of the catgut, or carbon fiber 
tows in this experiment, we found that portal pressures did not always 
respond consistently when multiple measurements were made. The measured 
pressures in some animals responded sluggishly as ligatures were 
tightened around the portal vein. In other animals, the slightest 
decrease in lumen diameter seemed to stimulate a marked pressure 
response. In this study, we used sacrificable mesenteric veins to make 
our measurements. Perhaps direct catheterization of the portal vein 
would provide pressures that are less subject to error. 
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VIII. APPENDIX: INFORMATION ON T'<IE USE OF ANIMALS IN RESEARCH 
AND TEACHING 
This research was conducted according to the rules and regulations 
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